BioSpace News Archive

The Alzheimer’s Research and Prevention Foundation announces Dr. Chris Walling as its new Vice President of Education and Outreach.

In2Bones Global, Inc. announces clearance from the U.S. Food and Drug Administration to market the Quantum™ Total Ankle..

Teleflex Incorporated (NYSE: TFX) announced today that financial results for the fourth quarter and full year 2019 will be released before market open on Thursday, February 20, 2020. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, February 20, 2020.

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced today its participation in the BIO CEO & Investor Conference being held at the Marriott Marquis in New York, February 10-11, 2020.

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today reported financial results for its fiscal 2020 first quarter.

Landos Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases, today announced that Dr. Josep Bassaganya-Riera, Chairman, President, and Chief Executive Officer, will present a company overview at the Annual BIO CEO & Investor Conference

Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products that meet patients’ unmet needs and solve therapeutic problems, announced today that it had a constructive face-to-face pre-Investigational New Drug (IND) Application meeting with the U.S. Food and Drug Administration (FDA) for its drug candidate, AQST-108,

SMART’s G-EYE® 760R colonoscope, incorporating its G-EYE® Balloon Technology designed to increase the detection of cancerous polyps in colonoscopy, will become available by FUJIFILM Europe with its state-of-the-art ELUXEO system, as part of the newly formed strategic distribution partnership with FUJIFILM Corporation.

Imara Inc., a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, known as hemoglobinopathies, today announced the appointment of Joelle Lufkin as its Senior Vice President of Development

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, has joined forces with the 25-30 million Americans living with a rare disease and health care advocates around the world for Rare Disease Day® on February 29.